{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:40:00Z","timestamp":1792024800509,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008895","name":"Tertiary Education Trust Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.phrs.2025.107602","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T22:49:24Z","timestamp":1736894964000},"page":"107602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Phenolic acids from Anisopus mannii modulates phosphofructokinase 1 to improve glycemic control in patients with type 2 diabetes: A double-blind, randomized, clinical trial"],"prefix":"10.1016","volume":"212","author":[{"given":"Peter U.","family":"Amadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justice O.","family":"Osuoha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidi N.","family":"Ekweogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha J.","family":"Jarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esienanwan E.","family":"Efiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince C.","family":"Odika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chioma","family":"Ejiofor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluchi","family":"Aloy-Amadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind S.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiamaka W.","family":"Adumekwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailun","family":"Gaowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"de Courten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel N.","family":"Agomuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107602_bib1","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in Type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2025.107602_bib2","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2337\/dc07-0627","article-title":"Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes","volume":"30","author":"Goldstein","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2025.107602_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2025.107602_bib4","doi-asserted-by":"crossref","unstructured":"2018 Clinical Practice Guidelines Committees. Can J Diabetes 42, A6\u2013A16, 2018.","DOI":"10.1016\/S1499-2671(17)31026-2"},{"key":"10.1016\/j.phrs.2025.107602_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2025.107602_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.phrs.2025.107602_bib7","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.2337\/dcS15-3007","article-title":"Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes","volume":"39","author":"Cahn","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2025.107602_bib8","unstructured":"Magliano, D.J., Boyko, E.J. & Committee, I.D.A. 10th edition scientific. IDF DIABETES ATLAS. IDF DIABETES ATLAS [Internet]. Brussels 1\u2013141 (2021)."},{"key":"10.1016\/j.phrs.2025.107602_bib9","first-page":"30","article-title":"Naturopathic Medicine and Type 2 Diabetes: A Retrospective Analysis from an Academic Clinic","volume":"11","author":"Bradley","year":"2006","journal-title":"Alter. Med. Rev."},{"key":"10.1016\/j.phrs.2025.107602_bib10","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2105\/AJPH.92.10.1648","article-title":"Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey","volume":"92","author":"Yeh","year":"2002","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.phrs.2025.107602_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2023.101808","article-title":"Use of herbal medicines for the management of type 2 diabetes: A systematic review of qualitative studies","volume":"53","author":"Sriraman","year":"2023","journal-title":"Complement Ther. Clin. Pract."},{"key":"10.1016\/j.phrs.2025.107602_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.777561","article-title":"Effectiveness of medicinal plants for glycaemic control in type 2 diabetes: an overview of meta-analyses of clinical trials","volume":"12","author":"Willcox","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2025.107602_bib13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2025.107602_bib14","article-title":"Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds","author":"Chang","year":"2013","journal-title":"Evid. Based Complement Altern. Med 2013"},{"key":"10.1016\/j.phrs.2025.107602_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jtcme.2017.08.012","article-title":"An update on natural compounds in the remedy of diabetes mellitus: a systematic review","volume":"8","author":"Choudhury","year":"2017","journal-title":"J. Tradit. Complement Med"},{"key":"10.1016\/j.phrs.2025.107602_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S2221-1691(12)60032-X","article-title":"An overview on antidiabetic medicinal plants having insulin mimetic property","volume":"2","author":"Patel","year":"2012","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.phrs.2025.107602_bib17","doi-asserted-by":"crossref","DOI":"10.1515\/jcim-2012-0037","article-title":"Hypoglycemic activity of the Anisopus mannii N. E. Br. methanolic leaf extract in normal and alloxan-induced diabetic mice","volume":"10","author":"Zaruwa","year":"2013","journal-title":"J. Complement Integr. Med"},{"key":"10.1016\/j.phrs.2025.107602_bib18","doi-asserted-by":"crossref","unstructured":"A. Tsopmo, Chemical constituents from the bark of Anisopus mannii. https:\/\/doi.org\/10.1139\/v08-170 87, 397\u2013400 (2009).","DOI":"10.1139\/v08-170"},{"key":"10.1016\/j.phrs.2025.107602_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5455\/jice.20150106124652","article-title":"Chemical composition and antimicrobial activity of hexane leaf extract of Anisopus mannii (Asclepiadaceae)","volume":"4","author":"Musa","year":"2015","journal-title":"J. Inter. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2025.107602_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.36108\/jbmb\/4202.20.0130","article-title":"Effects of methanolic extracts of anisopus mannii leaves on blood glucose and organ weights of wistar rats with alloxan induced-diabetes","volume":"2","author":"Muhammadu","year":"2024","journal-title":"J. Biochem Mol. Biol."},{"key":"10.1016\/j.phrs.2025.107602_bib21","doi-asserted-by":"crossref","DOI":"10.2202\/1553-3840.1482","article-title":"Potent hypoglycemic effect of Nigerian anti-diabetic medicinal plants","volume":"8","author":"Manosroi","year":"2011","journal-title":"J. Complement Integr. Med"},{"key":"10.1016\/j.phrs.2025.107602_bib22","article-title":"Effect of coadministration of glibenclamide and methanolic stem extract of Anisopus mannii N.E.Br. (Apocynaceae) on glucose homeostasis and lipid profile in streptozotocin\/nicotinamide-induced diabetic rats","author":"Chika","year":"2019","journal-title":"Natl. J. Physiol. Pharm. Pharm."},{"key":"10.1016\/j.phrs.2025.107602_bib23","first-page":"397","article-title":"Chemical constituents from the bark of Anisopus mannii","volume":"87","author":"Tsopmo","year":"2009","journal-title":"https:\/\/doi. Org. \/10. 1139\/v08-170"},{"key":"10.1016\/j.phrs.2025.107602_bib24","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1021\/acs.jnatprod.5b00258","article-title":"Bisleuconothine A Induces Autophagosome Formation by Interfering with AKT-mTOR Signaling Pathway","volume":"78","author":"Wong","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2025.107602_bib25","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.18632\/oncotarget.7190","article-title":"Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling","volume":"7","author":"Kong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2025.107602_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020324","article-title":"Steamed Ginger May Enhance Insulin Secretion through KATP Channel Closure in Pancreatic \u03b2-Cells Potentially by Increasing 1-Dehydro-6-Gingerdione Content","volume":"12","author":"Nam","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2025.107602_bib27","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbrc.2017.05.160","article-title":"Phytol increases adipocyte number and glucose tolerance through activation of PI3K\/Akt signaling pathway in mice fed high-fat and high-fructose diet","volume":"489","author":"Wang","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.phrs.2025.107602_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5455\/jice.20150106124652","article-title":"Chemical composition and antimicrobial activity of hexane leaf extract of Anisopus mannii (Asclepiadaceae)","volume":"4","author":"Musa","year":"2015","journal-title":"J. Inter. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2025.107602_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51808-6","article-title":"Structural basis for allosteric regulation of human phosphofructokinase-1","volume":"15","author":"Lynch","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107602_bib30","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp. Mol. Med. 2016 48:3"},{"key":"10.1016\/j.phrs.2025.107602_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2850","article-title":"Assessing the potential of glucokinase activators in diabetes therapy","volume":"8","author":"Matschinsky","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2025.107602_bib32","article-title":"A phase I open-label clinical trial to study drug-drug interactions of Dorzagliatin and Sitagliptin in patients with type 2 diabetes and obesity","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107602_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20080595","article-title":"Glucokinase and molecular aspects of liver glycogen metabolism","volume":"414","author":"Agius","year":"2008","journal-title":"Biochem J."},{"key":"10.1016\/j.phrs.2025.107602_bib34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/07315724.2020.1815249","article-title":"Okra Modulates Regulatory Enzymes and Metabolites of Glucose-Utilizing Pathways in Diabetic Rats","volume":"40","author":"Amadi","year":"2021","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.phrs.2025.107602_bib35","unstructured":"Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers Pharmacology and Toxicology Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. (2005)."},{"key":"10.1016\/j.phrs.2025.107602_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s13300-019-0619-1","article-title":"A View Beyond HbA1c: Role of Continuous Glucose Monitoring","volume":"10","author":"Chehregosha","year":"2019","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.phrs.2025.107602_bib37","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/JME-17-0138","article-title":"IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants","volume":"60","author":"Denroche","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2025.107602_bib38","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007708","article-title":"Immunologic and metabolic biomarkers of \u03b2-cell destruction in the diagnosis of type 1 diabetes","volume":"2","author":"Lebastchi","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"1 10","key":"10.1016\/j.phrs.2025.107602_bib39","first-page":"1","article-title":"Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic \u03b2-cells","volume":"10","author":"Haythorne","year":"2019","journal-title":"Nat. Commun. 2019"},{"key":"10.1016\/j.phrs.2025.107602_bib40","first-page":"1","article-title":"Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic \u03b2-cells","volume":"10","author":"Haythorne","year":"2019","journal-title":"Nat. Commun. 2019 10:1"},{"key":"10.1016\/j.phrs.2025.107602_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1210\/er.2003-0026","article-title":"The cellular fate of glucose and its relevance in type 2 diabetes","volume":"25","author":"Bouch\u00e9","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2025.107602_bib42","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjc.6600547","article-title":"Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death","volume":"87","author":"Aft","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phrs.2025.107602_bib43","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2025.107602_bib44","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.molcel.2022.02.028","article-title":"Hexokinase 1 cellular localization regulates the metabolic fate of glucose","volume":"82","author":"De Jesus","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.107602_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.phrs.2025.107602_bib46","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1073\/pnas.050588097","article-title":"Reevaluation of the accepted allosteric mechanism of phosphofructokinase from Bacillus stearothermophilus","volume":"97","author":"Kimmel","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107602_bib47","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1016\/S0021-9258(17)34524-6","article-title":"Turnover of hepatic phosphofructokinase in normal and diabetic rats. Role of insulin and peptide stabilizing factor","volume":"253","author":"Dunaway","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107602_bib48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/1873-3468.13604","article-title":"Type 2 diabetes differentially affects the substrate saturation kinetic attributes of erythrocyte hexokinase and phosphofructokinase","volume":"594","author":"Bhise","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2025.107602_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0006-291X(84)91419-0","article-title":"Decreases in hepatic fructose-2,6-bisphosphate level and fructose-6-phosphate,2-kinase activity in diabetic mice: a close relationship to the development of ketosis","volume":"120","author":"Sumi","year":"1984","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.phrs.2025.107602_bib50","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.2002.282.1.E38","article-title":"Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes","volume":"282","author":"Wu","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2025.107602_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/BJ20040752","article-title":"6-Phosphofructo-2-kinase\/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis","volume":"381","author":"Rider","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.phrs.2025.107602_bib52","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/nu10060713","article-title":"Ferulic Acid Supplementation Improves Lipid Profiles, Oxidative Stress, and Inflammatory Status in Hyperlipidemic Subjects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","volume":"10","author":"Bumrungpert","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2025.107602_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/j.1750-3841.2010.01907.x","article-title":"Effect of oryzanol and ferulic acid on the glucose metabolism of mice fed with a high-fat diet","volume":"76","author":"Son","year":"2011","journal-title":"J. Food Sci."},{"key":"10.1016\/j.phrs.2025.107602_bib54","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00580-015-2119-7","article-title":"Antioxidant and antidiabetic effects of gallic and protocatechuic acids: a structure\u2013function perspective","volume":"24","author":"Adefegha","year":"2015","journal-title":"Comp. Clin. Path"},{"key":"10.1016\/j.phrs.2025.107602_bib55","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.toxrep.2021.07.011","article-title":"Combined effect of metformin and gallic acid on inflammation, antioxidant status, endoplasmic reticulum (ER) stress and glucose metabolism in fructose-fed streptozotocin-induced diabetic rats","volume":"8","author":"Obafemi","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.phrs.2025.107602_bib56","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/13880209.2023.2181359","article-title":"Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury","volume":"61","author":"Xu","year":"2023","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.phrs.2025.107602_bib57","article-title":"Gallic acid ameliorates diabetic steatohepatitis in db\/db mice fed with a high-fat diet","volume":"19","author":"Wang","year":"2025","journal-title":"J. Agric. Food Res"},{"key":"10.1016\/j.phrs.2025.107602_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2221-1691.276317","article-title":"Syringic acid improves oxidative stress and mitochondrial biogenesis in the liver of streptozotocin-induced diabetic rats","volume":"10","author":"Sabahi","year":"2020","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.phrs.2025.107602_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2337\/cd20-0101","article-title":"A Common Drug Causing a Common Side Effect at an Uncommon Time: Metformin-Induced Chronic Diarrhea and Weight Loss After Years of Treatment","volume":"39","author":"Subramaniam","year":"2021","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.phrs.2025.107602_bib60","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1210\/jc.2003-030861","article-title":"Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial","volume":"89","author":"Schernthaner","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2025.107602_bib61","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1210\/jc.2002-021225","article-title":"Efficacy of glyburide\/metformin tablets compared with initial monotherapy in type 2 diabetes","volume":"88","author":"Garber","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2025.107602_bib62","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(09)60222-1","article-title":"Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance","volume":"373","author":"Kawamori","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2025.107602_bib63","unstructured":"Bethesda. LiverTox. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury Bookshelf ID: NBK547852 (2012)."},{"key":"10.1016\/j.phrs.2025.107602_bib64","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/dc11-1465","article-title":"Quantifying the effect of metformin treatment and dose on glycemic control","volume":"35","author":"Hirst","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2025.107602_bib65","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/cd23-as01","article-title":"Standards of Care in Diabetes\u20142023 Abridged for Primary Care Providers","volume":"41","author":"Feldman","year":"2023","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.phrs.2025.107602_bib66","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2337\/dc07-0627","article-title":"Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes","volume":"30","author":"Goldstein","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2025.107602_bib67","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCOUTCOMES.116.002901","article-title":"Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence","volume":"9","author":"Rodr\u00edguez-Guti\u00e9rrez","year":"2016","journal-title":"Circ. Cardiovasc Qual. Outcomes"},{"key":"10.1016\/j.phrs.2025.107602_bib68","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/CIRCOUTCOMES.116.002901","article-title":"Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence","volume":"9","author":"Rodr\u00edguez-Guti\u00e9rrez","year":"2016","journal-title":"Circ. Cardiovasc Qual. Outcomes"},{"key":"10.1016\/j.phrs.2025.107602_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/dc09-1661","article-title":"Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)","volume":"33","author":"Kahn","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2025.107602_bib70","article-title":"Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial","volume":"6","author":"van der Aa","year":"2016","journal-title":"Nutr. Diabetes 2016 6:8"},{"key":"10.1016\/j.phrs.2025.107602_bib71","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1001\/archinte.162.21.2428","article-title":"The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes","volume":"162","author":"Tong","year":"2002","journal-title":"Arch. Intern Med"},{"key":"10.1016\/j.phrs.2025.107602_bib72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/oby.2009.155","article-title":"Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical)","volume":"18","author":"Kopelman","year":"2010","journal-title":"Obes. (Silver Spring)"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825000271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:39:15Z","timestamp":1740526755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825000271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":72,"alternative-id":["S1043661825000271"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107602","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenolic acids from Anisopus mannii modulates phosphofructokinase 1 to improve glycemic control in patients with type 2 diabetes: A double-blind, randomized, clinical trial","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107602"}}